Delivery Order SPE2DR25D2013-SPE2DR26F5QLE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of RINVOQ ER 15 mg tablets (30-unit packages) valued at $34,723.92. This is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) valued at $3,352.74. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order...
- The Defense Logistics Agency awarded a $5,908.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for RINVOQ ER 30 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of October 27, 2025, and performance to occur at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $6,223.32 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion prime vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of RINVOQ ER 45 mg tablets (UU 28s packaging) with a firm fixed price ceiling value of $7,483.54. This is a non-set-aside competitive award with an ultimate completion date of November 4, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of RINVOQ ER 15 mg tablets in a quantity of 30 units, with a ceiling value of $6,888.58. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of...
- The Defense Logistics Agency awarded a delivery order valued at $13,037.95 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on October 23, 2025, with completion scheduled for October 24, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $40,502.39. This firm fixed-price delivery order, with an ultimate completion date of October 29, 2025, represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $13,565.47 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $16,761.64 and an ultimate completion date of July 25, 2025. The contract was competitively awarded without any set-aside designation, and performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5QLEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for supply of RINVOQ ER 15 mg tablets (30-unit packages) with a ceiling value of $42,673.11. This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and has demonstrated significant capability in meeting federal medical procurement requirements. The company's extensive federal contract portfolio with DLA covers a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for RINVOQ ER, an immunosuppressant medication used in treating rheumatoid arthritis and other autoimmune conditions, reflects the contractor's ongoing role as a critical vendor supporting military and veteran healthcare systems through open competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.7k | 11/4/25 |